Provenant AI Labs Contact

Telemedicine edge appliance

Telemed AI+ Remote Consultation Edition

Designed for remote consultation workflows where clinicians need secure video consultation, local patient context, and care-team coordination support.

View all products

Telemedicine edge appliance

A scoped technology pathway for qualified evaluation.

Designed for remote consultation workflows where clinicians need secure video consultation, local patient context, and care-team coordination support.

Public materials describe research and engineering scope. Any future configuration depends on validation, governance, procurement, site requirements and qualified stakeholder review.

Telemed AI+ Remote Consultation Edition prototype or product concept
Illustrative product or prototype image. Configuration, availability and validation status depend on the qualified programme scope.

Product context

Designed to be discussed in context, not in isolation.

The visual represents the product or prototype concept associated with this route. The surrounding programme, workflow, hardware and governance requirements determine whether a future evaluation is appropriate.

Public capabilities

What this pathway can include.

  • Remote consultation workflow support
  • Local patient-context review during virtual care
  • Care-team communication and follow-up readiness
  • Detailed specifications shared only during qualified enquiry

Suitable for

Telemedicine programs, remote care teams, outpatient follow-up services

Deployment use cases

  • Remote doctor-patient consultation
  • Virtual follow-up coordination support
  • Distributed care coordination pilots

Qualified enquiry

Bring the workflow. We’ll define the next responsible step.

This page is for research, pilot and qualified programme discussions. It is not a claim of clinical approval or general commercial availability.

Pilot & Regulatory Notice

Medi AI+ is currently a pre-clinical engineering programme. Product concepts and pilot configurations shown on this website are for stakeholder evaluation, controlled pilot planning, and qualified commercial discussion only. They are not represented as HSA-registered or approved medical devices, diagnostic systems, treatment systems, autonomous clinical decision-making, or substitutes for professional clinical judgement. It is not approved for diagnosis, treatment, or unsupervised clinical use. Any Singapore deployment must undergo appropriate institutional review, clinical governance, cybersecurity assessment, procurement checks, PDPA/data protection review, and, where applicable, Health Sciences Authority (HSA) medical-device classification, registration, licensing, and approval processes before clinical or operational use.